Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.


Drexel University Hosts Screening Of The American Nurse

Drexel University, a leader in nursing and health care education, invites nurses to a complimentary screening of The American Nurse on Tuesday, and Wednesday.  The American Nurse Project aims to elevate the voice of nurses by capturing their personal stories through photography and film. The Chattanooga show times will be on  Tuesday at noon. RSVP at  ... (click for more)

Erlanger Adds Orthopedic Specialists, Bringing Total Number Of Orthopedic Providers To 25

The Erlanger Health System announced the addition of three orthopedic surgeons, an interventional physiatrist, a nurse practitioner and a physical therapist to UT Erlanger Orthopaedics; bringing the total number of Erlanger orthopedic providers to 25. Orthopedic providers from the  Chattanooga Bone and Joint Center who are joining Erlanger are Dr. David ... (click for more)

Truck Bursts Into Flames On I-75 Near Tunnel Hill; Traffic At Standstill For Hours

A truck burst into flames after wrecking with another vehicle on I-75 near Tunnel Hill on Saturday afternoon. There were injuries reported in the fiery accident in the southbound lanes. Traffic was at a standstill for several hours. Long lines of vehicles detoured onto Highway 41 into Ringgold. The wreck was just inside Catoosa County, Ga. (click for more)

Representative Jimmy Duncan Endorses Donald Trump For President

Representative John J. Duncan, Jr., one of the most senior Republicans in the House and the only Republican remaining in Congress who voted against the Iraq War today endorsed Donald Trump for president. Rep. Duncan said, “With only four percent of the world’s population, we buy 25 percent of the world’s goods. Every country wants into our markets. We have tremendous leverage ... (click for more)

Jill Levine Is An Educational Rock Star

No one has covered the Hamilton County Department of Education drama better than Roy Exum.  Thank you, Roy, but I take issue with your unnamed sources.  Professional jealousy and sour grape darts should not be anonymous.   HCDE is so dysfunctional, and there is good cause to place this public organization under a microscope, dissect it into pieces and discard all ... (click for more)

Roy Exum: Settle It With A Vote

The Merriam-Webster Dictionary, which I consider a pretty good authority on what words really mean, defines “freedom” in this way:  “The quality or state of being free: such as, (a) the absence of necessity, coercion, or constraint in choice or action; (b) liberation from slavery or restraint or from the power of another; (c) independence -- the quality or state of being exempt ... (click for more)